OmniAb (OABI) Other Working Capital Changes (2021 - 2026)
OmniAb (OABI) reported Other Working Capital Changes of -$512000.0 for Q1 2026, down 801.37% year-over-year from $73000.0 in Q1 2025, and up 13.07% quarter-over-quarter from -$589000.0 in Q4 2025.
OmniAb (OABI) Other Working Capital Changes (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Other Working Capital Changes data on file, last reported at -$512000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$512000.0, down 801.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 million (down 25.86% YoY), and the FY2025 annual result was -$1.6 million, up 34.32% from the prior year.
- Other Working Capital Changes rose to -$512000.0 in Q1 2026 per OABI's latest filing, from -$589000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.6 million in Q3 2023 and troughed at -$3.0 million in Q1 2023.
- A 5-year average of -$297588.2 and a median of -$208000.0 in 2025 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1576.92% in 2023 and fell as far as 4256.45% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$62000.0 in 2022, then tumbled by 4256.45% to -$2.7 million in 2023, then gained by 22.44% to -$2.1 million in 2024, then soared by 71.89% to -$589000.0 in 2025, then advanced by 13.07% to -$512000.0 in 2026.
- Business Quant data shows OABI's Other Working Capital Changes at -$512000.0 in Q1 2026, -$589000.0 in Q4 2025, and -$876000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | -589,000.00 |
| Dec 31, 2025 | -589,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -2.10 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | 888,000.00 |
| Sep 30, 2024 | 888,000.00 |
| Jun 30, 2024 | -602,000.00 |
| Jun 30, 2024 | -602,000.00 |
| Mar 31, 2024 | -627,000.00 |
| Mar 31, 2024 | -627,000.00 |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |